Daiichi And J&J Alzheimer's Drugs Obtain Japanese Approval Recommendations
This article was originally published in PharmAsia News
Executive Summary
The first subcommittee on new drugs at Japan's Ministry of Health, Labor and Welfare recommended Daiichi Sankyo's memantine and Janssen Pharma's Reminil (galantamine) for approval